Acknowledgement
We thank Dong-Young Noh for providing human breast cancer tissues. This work was supported by National Academy of Sciences, ROK and National Research Foundation of Korea (NRF-2005-084-C00025) to C.H.C. and by Korea Research Institute of Standards and Science ("Establishment of measurement standards for Chemistry and Radiation," KRISS-2022-GP2022-0003), the Ministry of Science and ICT (MSIT), National Research Foundation of Korea (NRF-2016M3A7B6908929, NRF-2019M3A9F3065868, and NRF-2021M3C1C3097638) to H.M.Y. This study was approved by the Seoul National University Hospital (SNUH) Institutional Review Board (IRB) (approval No. 1207-119-420).
References
- Colin, E., Daniel, J., Ziegler, A., Wakim, J., Scrivo, A., Haak, T.B., Khiati, S., Denomme, A., Amati-Bonneau, P., Charif, M., et al. (2016). Biallelic variants in UBA5 reveal that disruption of the UFM1 cascade can result in early-onset encephalopathy. Am. J. Hum. Genet. 99, 695-703. https://doi.org/10.1016/j.ajhg.2016.06.030
- Daniel, J. and Liebau, E. (2014). The ufm1 cascade. Cells 3, 627-638. https://doi.org/10.3390/cells3020627
- Eckert, R.L., Mullick, A., Rorke, E.A., and Katzenellenbogen, B.S. (1984). Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique. Endocrinology 114, 629-637. https://doi.org/10.1210/endo-114-2-629
- Gannavaram, S., Connelly, P.S., Daniels, M.P., Duncan, R., Salotra, P., and Nakhasi, H.L. (2012). Deletion of mitochodrial associated ubiquitin fold modifier protein Ufm1 in Leishmania donovani results in loss of beta-oxidation of fatty acid and blocks cell division in the amastigote stage. Mol. Microbiol. 86, 187-198. https://doi.org/10.1111/j.1365-2958.2012.08183.x
- Hamilton, E.M.C., Bertini, E., Kalaydjieva, L., Morar, B., Dojcakova, D., Liu, J., Vandeever, A., Curiel, J., Persoon, C.M., Diadato, D., et al. (2017). UFM1 founder mutation in the Roma population causes recessive variant of H-ABC. Neulorogy 89, 1821-1828.
- Heride, C., Urbe, S., and Clague, M.J. (2014). Ubiquitin code assembly and disassembly. Curr. Biol. 24, R215-R220.
- Hu, Z., Wang, X., Li, D., Cao, L., Cui, H., and Xu, G. (2021). UFBP1, a key component in ufmylation, enhances drug sensitivity by promoting proteasomal degradation of oxidative stress-response transcription factor Nrf2. Oncogene 40, 647-662. https://doi.org/10.1038/s41388-020-01551-1
- Jensen, E. (2012). A conversation with Elwood Jensen. Interview by David D. Moore. Annu. Rev. Physiol. 74, 1-11. https://doi.org/10.1146/annurev-physiol-020911-153327
- Jozwik, K.M. and Carroll, J.S. (2012). Pioneer factors in hormone-dependent cancers. Nat. Rev. Cancer 12, 381-385. https://doi.org/10.1038/nrc3263
- Kang, S.H., Kim, G.R., Seong, M., Baek, S.H., Seol, J.H., Bang, O.S., Ovaa, H., Tatsumi, K., Komatsu, M., Tanaka, K., et al. (2007). Two novel ubiquitin-fold modifier 1 (Ufm1)-specific proteases, UfSP1 and UfSP2. J. Biol. Chem. 282, 5256-5262. https://doi.org/10.1074/jbc.M610590200
- Komatsu, M., Chiba, T., Tatsumi, K., Iemura, S., Tanida, I., Okazaki, N., Ueno, T., Kominami, E., Natsume, T., and Tanaka, K. (2004). A novel protein-conjugating system for Ufm1, a ubiquitin-fold modifier. EMBO J. 23, 1977-1986. https://doi.org/10.1038/sj.emboj.7600205
- Kuiper, G.G., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J.A. (1996). Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U. S. A. 93, 5925-5930. https://doi.org/10.1073/pnas.93.12.5925
- Le Romancer, M., Poulard, C., Cohen, P., Sentis, S., Renoir, J., and Corbo, L. (2011). Cracking the estrogen receptor's posttranslational code in breast tumors. Endocr. Rev. 32, 597-622. https://doi.org/10.1210/er.2010-0016
- Lemaire, K., Moura, R.F., Granvik, M., Igoillo-Esteve, M., Hohmeier, H.E., Hendrickx, N., Newgard, C.B., Waelkens, E., Cnop, M., and Schuit, F. (2011). Ubiquitin fold modifier 1 (UFM1) and its target UFBP1 protect pancreatic beta cells from ER stress-induced apoptosis. PLoS One 6, e18517. https://doi.org/10.1371/journal.pone.0018517
- Lin, J., Xie, X., Weng, X., Qiu, S., Yoon, C., Lian, N., Xie, J., Wang, J., Lu, J., Chen, Q., et al. (2019). UFM1 suppressed invasive activities of gastric cancer cells by attenuating the expression of PDK1 through PI3K/AKT signaling. J. Exp. Clin. Cancer Res. 38, 410. https://doi.org/10.1186/s13046-019-1416-4
- Liu, J., Guan, D., Dong, M., Yang, J., Wei, H., Liang, Q., Song, J., Xu, L., Bai, J., Liu, C., et al. (2020). UFMylation maintains tumor suppressor p53 stability by antagonizing its ubiquitination. Nat. Cell Biol. 22, 1056-1063. https://doi.org/10.1038/s41556-020-0559-z
- Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995). The nuclear receptor superfamily: the second decade. Cell 83, 835-839. https://doi.org/10.1016/0092-8674(95)90199-X
- Nilsson, S., Makela, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., Enmark, E., Pettersson, K., Warner, M., and Gustafsson, J.A. (2001). Mechanisms of estrogen action. Physiol. Rev. 81, 1535-1565. https://doi.org/10.1152/physrev.2001.81.4.1535
- Preisler-Mashek, M.T., Solodin, N., Stark, B.L., Tyriver, M.K., and Alarid, E.T. (2002). Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-alpha. Am. J. Physiol. Endocrinol. Metab. 282, E891-E898. https://doi.org/10.1152/ajpendo.00353.2001
- Qin, B., Yu, J., Nowsheen, S., Wang, M., Tu, X., Liu, T., Li, H., Wang, L., and Lou, Z. (2019). UFL1 promotes histone H4 ufmylation and ATM activation. Nat. Commun. 10, 1242. https://doi.org/10.1038/s41467-019-09175-0
- Reid, G., Hubner, M.R., Metivier, R., Brand, H., Denger, S., Manu, D., Beaudouin, J., Ellenberg, J., and Gannon, F. (2003). Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11, 695-707. https://doi.org/10.1016/S1097-2765(03)00090-X
- Song, A., Wang, Y., Jiang, F., Yan, E., Zhou, J., Ye, J., Zhang, H., Ding, X., Li, G., Wu, Y., et al. (2021). Ubiquitin D promotes progression of oral squamous cell carcinoma via NF-kappa B signaling. Mol. Cells 44, 468-480. https://doi.org/10.14348/molcells.2021.2229
- Tatsumi, K., Yamamoto-Mukai, H., Shimizu, R., Waguri, S., Sou, Y.S., Sakamoto, A., Taya, C., Shitara, H., Hara, T., Chung, C.H., et al. (2011). The Ufm1-activating enzyme Uba5 is indispensable for erythroid differentiation in mice. Nat. Commun. 2, 181. https://doi.org/10.1038/ncomms1182
- Wang, Z., Gong, Y., Peng, B., Shi, R., Fan, D., Zhao, H., Zhu, M., Zhang, H., Lou, Z., Zhou, J., et al. (2019). MRE11 ufmylation promotes ATP activation. Nucleic Acids Res. 47, 4124-4135. https://doi.org/10.1093/nar/gkz110
- Yoo, H.M., Kang, S.H., Kim, J.Y., Lee, J.E., Seong, M.W., Lee, S.W., Ka, S.H., Sou, Y., Komatsu, M., Tanaka, K., et al. (2014). Modification of ASC1 by UFM1 is crucial for ERα transactivation and breast cancer development. Mol. Cell 56, 261-274. https://doi.org/10.1016/j.molcel.2014.08.007
- Yoo, H.M., Park, J.H., Jeon, Y.J., and Chung, C.H. (2015). Ubiquitin-fold modifier 1 acts as a positive regulator of brest cancer. Front. Endocrinol. (Lausanne) 6, 36. https://doi.org/10.3389/fendo.2015.00036
- Zhang, Y., Zhang, M., Wu, J., Lei, G., and Li, H. (2012). Transcriptional regulation of the Ufm1 conjugation system in response to disturbance of the endoplasmic reticulum homeostasis and inhibition of vesicle trafficking. PLoS One 7, e48587. https://doi.org/10.1371/journal.pone.0048587
- Zhou, W. and Slingerland, J.M. (2014). Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy. Nat. Rev. Cancer 14, 26-38. https://doi.org/10.1038/nrc3622